Dolby Laboratories (NYSE:DLB – Get Free Report) EVP Mark Andrew Sherman sold 2,491 shares of Dolby Laboratories stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $67.26, for a total value of $167,544.66. Following the completion of the transaction, the executive vice president owned 70,563 shares in the company, valued at $4,746,067.38. This trade represents a 3.41% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Mark Andrew Sherman also recently made the following trade(s):
- On Tuesday, December 16th, Mark Andrew Sherman sold 9,109 shares of Dolby Laboratories stock. The shares were sold at an average price of $66.73, for a total transaction of $607,843.57.
- On Monday, December 1st, Mark Andrew Sherman sold 4,500 shares of Dolby Laboratories stock. The shares were sold at an average price of $67.56, for a total transaction of $304,020.00.
Dolby Laboratories Stock Up 0.4%
Shares of Dolby Laboratories stock traded up $0.29 on Wednesday, reaching $67.09. The stock had a trading volume of 575,384 shares, compared to its average volume of 610,696. The stock has a market capitalization of $6.41 billion, a P/E ratio of 25.51 and a beta of 0.89. The company has a 50 day moving average price of $66.88 and a 200 day moving average price of $71.25. Dolby Laboratories has a 1 year low of $64.02 and a 1 year high of $89.66.
Dolby Laboratories Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were paid a dividend of $0.36 per share. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a yield of 2.1%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 54.75%.
Analyst Ratings Changes
Several research analysts recently issued reports on DLB shares. Barrington Research reduced their target price on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday. Rosenblatt Securities decreased their price objective on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Wednesday, November 19th. Finally, Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 target price on the stock. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $92.00.
Get Our Latest Stock Analysis on DLB
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the company. Boothbay Fund Management LLC lifted its holdings in shares of Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after purchasing an additional 157 shares during the period. MAI Capital Management raised its position in Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after buying an additional 162 shares during the last quarter. Mitchell & Pahl Private Wealth LLC lifted its stake in Dolby Laboratories by 1.1% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker’s stock valued at $1,139,000 after acquiring an additional 170 shares during the period. Equitable Trust Co. lifted its stake in Dolby Laboratories by 3.3% during the 2nd quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock valued at $413,000 after acquiring an additional 177 shares during the period. Finally, Steward Partners Investment Advisory LLC boosted its holdings in shares of Dolby Laboratories by 13.9% in the 2nd quarter. Steward Partners Investment Advisory LLC now owns 1,587 shares of the electronics maker’s stock valued at $118,000 after acquiring an additional 194 shares during the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Large Cap Stock Definition and How to Invest
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- How to Invest in Insurance Companies: A GuideĀ
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- 10 Best Airline Stocks to Buy
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
